HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Legislation Adding SARMs to CSA Schedule III Introduced In Senate

Executive Summary

“By placing SARMs on the same schedule as other anabolic steroid, we’re ensuring a safer and more transparent marketplace," says Iowa Republica Chuck Grassley, who sponsored the bill with Rhode Island Democrat Sheldon Whitehouse.

You may also be interested in...



Arizona Supplement Firm’s Problems Start With COVID-19 Claims, Reach SARMS, ED Drug

CDER notes in update to COVID-19 enforcement and other actions that Umbrella Labs made unlawful claims to prevent and treat the virus. Announcement didn’t note those claims weren’t first among violations identified in a warning letter to the firm.

States’ Proposals To Age-Restrict Sports Nutrition Sales Miss Targeted Problems But Hit Retailers

MA and NY lawmakers propose prohibiting sales to consumers under 18 of supplements, OTC drugs for weight loss and muscle building and imposing $2,000 fines for violations. Supplement industry trade groups say the laws would not help solve eating disorders but would hammer retailers.

Massachusetts Bid Stalls To Age-Restrict Sales Of Bodybuilding, Weight Loss Supplements

"We spent a lot of time in Massachusetts trying to point out the flaws in the legislation," says CRN government relations chief Mike Greene. CRN and other stakeholders could focus on the Massachusetts bill because no other similar proposals surfaced in other state legislatures this year.

Related Content

Topics

UsernamePublicRestriction

Register

RS149447

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel